Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in Eisenmenger Syndrome
NCT00266162Phase 4Completed
- Sponsor
- Competence Network for Congenital Heart Defects
- Start
- Aug 2004
- Primary completion
- Feb 2008
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bosentan in Eisenmenger syndrome, sponsored by Competence Network for Congenital Heart Defects. Started Aug 2004; status: completed.
02
Drugs
bosentan
03
Conditions
Eisenmenger syndrome
Beyond the preview
Go deeper on NCT00266162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266162.